{"id":"carboxymethylcellulose-sodium-based-eye-drops","safety":{"commonSideEffects":[{"rate":"null","effect":"Eye irritation"}]},"_chembl":{"chemblId":"CHEMBL2109001","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This protective barrier helps to reduce friction between the eyelid and the eye, which can help to alleviate symptoms of dry eye syndrome. By providing a stable and consistent layer of lubrication, carboxymethylcellulose sodium eye drops can help to promote healing and reduce inflammation in the eye.","oneSentence":"Carboxymethylcellulose sodium eye drops work by forming a protective barrier on the surface of the eye to help soothe and lubricate dry eyes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:57.148Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of dry eye syndrome"}]},"trialDetails":[{"nctId":"NCT06913387","phase":"NA","title":"Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Evaporative Dry Eye","enrollment":60},{"nctId":"NCT03380624","phase":"PHASE4","title":"Tear Lipid Layer Thickness With Emollient Eye Drops","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2017-03-01","conditions":"Dry Eye Syndromes","enrollment":21},{"nctId":"NCT04485533","phase":"NA","title":"Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED","status":"UNKNOWN","sponsor":"VISUfarma SpA","startDate":"2020-07-06","conditions":"Dry Eye Syndromes","enrollment":90},{"nctId":"NCT02121847","phase":"PHASE4","title":"Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-04-03","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT01459588","phase":"PHASE3","title":"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10-01","conditions":"Dry Eye Syndromes","enrollment":315},{"nctId":"NCT01844388","phase":"PHASE3","title":"A Study to Compare a New Eye Drop Formulation With Refresh Contacts®","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-05-29","conditions":"Contact Lens Lubrication","enrollment":365},{"nctId":"NCT01294384","phase":"PHASE3","title":"Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-05-01","conditions":"Dry Eye Syndromes","enrollment":305},{"nctId":"NCT01886690","phase":"PHASE3","title":"A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-08-20","conditions":"Bilateral LASIK Surgery","enrollment":148},{"nctId":"NCT02007174","phase":"","title":"Bevacizumab Injection for Recurrent Pterygium","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2012-03","conditions":"Recurrent Pterygium","enrollment":38},{"nctId":"NCT02553772","phase":"PHASE3","title":"A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-01-06","conditions":"Dry Eye Syndromes","enrollment":242},{"nctId":"NCT02455050","phase":"PHASE3","title":"A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-12","conditions":"Dry Eye Syndromes","enrollment":79},{"nctId":"NCT01664949","phase":"PHASE3","title":"A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-01","conditions":"Dry Eye Disease","enrollment":460},{"nctId":"NCT00932477","phase":"NA","title":"Safety and Tolerability of Artificial Tears in Dry Eye Subjects","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-08","conditions":"Dry Eye Syndrome","enrollment":47},{"nctId":"NCT01010282","phase":"NA","title":"Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-11","conditions":"Dry Eye Syndrome","enrollment":288},{"nctId":"NCT00691197","phase":"PHASE2, PHASE3","title":"Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear","status":"COMPLETED","sponsor":"Allergan","startDate":"2008-03","conditions":"Ametropia","enrollment":246},{"nctId":"NCT01339936","phase":"PHASE2, PHASE3","title":"Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers","status":"COMPLETED","sponsor":"Optometric Technology Group Ltd","startDate":"2011-03","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT00544713","phase":"NA","title":"Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-09","conditions":"Dry Eye Syndrome","enrollment":228},{"nctId":"NCT00514852","phase":"NA","title":"Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-10","conditions":"Dry Eye Syndrome","enrollment":316}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Refresh Tears®","REFRESH PLUS®"],"phase":"phase_3","status":"active","brandName":"carboxymethylcellulose sodium based Eye Drops","genericName":"carboxymethylcellulose sodium based Eye Drops","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carboxymethylcellulose sodium eye drops work by forming a protective barrier on the surface of the eye to help soothe and lubricate dry eyes. Used for Treatment of dry eye syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}